ScholarLens Back to search
2006•Zhongguo redai yixueRequires access

:1009-9727(2006)02-267-02 Clinical observation on the results in treatment of chronic hepatitis B infections with interferon and thymosin

Huang Zh

Open publisher page 0 citations

Abstract

Objective To observe the clinical anti-HBV-replication effect of IFN-a lb combined with large dose of thymopeptide on patients with chronic hepatitis B. Methods 77 patients with chronic hepatitis B whose HBeAg and HBV-DNA were positive were enrolled in this research and divided into two groups randomly:treatment group and control group.23 patients in control group were treated in the same procedure except without using thymopeptide. Results In treatment group,the negative rates of HBeAg and HBV-DNA were 64.8% and 68.5% by the and of the remedy.In control group,the percentage of the above two parameters were 39.1%and 43.5%respectively.The comparison of the three parameters between the two groups showed a significant difference(P0.05).No obvious toxic side reactions occurred in the course of treatment. Conclusion The antiviral effect could be enhanced by IFN-a lb combined with thymopeptide.

About this research paper

What this paper is about

Objective To observe the clinical anti-HBV-replication effect of IFN-a lb combined with large dose of thymopeptide on patients with chronic hepatitis B. Methods 77 patients with chronic hepatitis B whose HBeAg and HBV-DNA were positive were enrolled in this research and divided into two groups randomly:treatment group and control group.23 patients in control group were treated in the same procedure except without using thymopeptide. Results In treatment group,the negative rates of HBeAg and HBV-DNA were 64.8% and 68.5% by the and of the remedy.In control group,the percentage of the above two parameters were 39.1%and 43.5%respectively.The comparison of the three parameters between the two groups showed a significant difference(P0.05).No obvious toxic side reactions occurred in the course of treatment. Conclusion The antiviral effect could be enhanced by IFN-a lb combined with thymopeptide.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical anti-HBV-replication effect of IFN-a lb combined with large dose of thymopeptide on patients with chronic hepatitis B. Methods 77 patients with chronic hepatitis B whose HBeAg and HBV-DNA were positive were enrolled in this research and divided into two groups randomly:treatment group and control group.23 patients in control group were treated in the same procedure except without using thymopeptide. Results In treatment group,the negative rates of HBeAg and HBV-DNA were 64.8% and 68.5% by the and of the remedy.In control group,the percentage of the above two parameters were 39.1%and 43.5%respectively.The comparison of the three parameters between the two groups showed a significant difference(P0.05).No obvious toxic side reactions occurred in the course of treatment. Conclusion The antiviral effect could be enhanced by IFN-a lb combined with thymopeptide.

Key concepts: HBeAg, Chronic hepatitis, Thymosin, Medicine, Internal medicine, Gastroenterology, Interferon, Antiviral treatment

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
:1009-9727(2006)02-267-02 Clinical observation on the results in treatment of chronic hepatitis B infections with interferon and thymosin — Research Paper | ScholarLens